People taking popular GLP-1 weight-loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound may be shedding pounds, but a new study suggests they are also moving less. People with obesity who lost weight while taking popular medications such as Ozempic, Wegovy, Zepbound, and similar drugs became significantly less physically active, according to research presented at ENDO [...]

Tiny particles from the gut may be carrying aging signals throughout the body, offering a surprising new clue to chronic disease. Researchers at the Marshall University Joan C. Edwards School of Medicine have uncovered new evidence that microscopic particles produced in the gut may contribute to the inflammation and chronic diseases often associated with aging. [...]

A major new review says “yo-yo dieting” may not be nearly as harmful as people have been told. Repeated cycles of losing weight and gaining it back, often called “yo-yo dieting” or weight cycling, are frequently described as harmful to health and metabolism. Some experts have even suggested that repeatedly regaining weight may be worse [...]

A new “Trojan horse” weight-loss drug sneaks extra metabolic power into cells and delivers striking results in mice. Researchers at Helmholtz Munich have developed a new drug strategy that could improve treatment for obesity and type 2 diabetes. Led by metabolism scientist Prof Timo D. Müller, the team created a hybrid molecule that uses the [...]